These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34208199)

  • 1. Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters.
    Kowalska M; Fijałkowski Ł; Nowaczyk A
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cynomorium songaricum extracts functionally modulate transporters of gamma-aminobutyric acid and monoamine.
    Zhao G; Wang J; Qin GW; Guo LH
    Neurochem Res; 2010 Apr; 35(4):666-76. PubMed ID: 20084455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
    Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
    Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE
    J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain.
    Vilpoux C; Leroux-Nicollet I; Naudon L; Raisman-Vozari R; Costentin J
    Neuropharmacology; 2000 Apr; 39(6):1075-82. PubMed ID: 10727718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
    Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
    Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
    Ribeiro P; Patocka N
    Parasitol Int; 2013 Dec; 62(6):629-38. PubMed ID: 23800409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
    Moll GH; Mehnert C; Wicker M; Bock N; Rothenberger A; Rüther E; Huether G
    Brain Res Dev Brain Res; 2000 Feb; 119(2):251-7. PubMed ID: 10675775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional activation of monoamine transporters by luteolin and apigenin isolated from the fruit of Perilla frutescens (L.) Britt.
    Zhao G; Qin GW; Wang J; Chu WJ; Guo LH
    Neurochem Int; 2010 Jan; 56(1):168-76. PubMed ID: 19815045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
    Jayanthi LD; Ramamoorthy S
    AAPS J; 2005 Oct; 7(3):E728-38. PubMed ID: 16353949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of sialic acid in the regulation of γ--aminobutyric acid uptake activity of γ-aminobutyric acid transporter 1.
    Hu J; Fei J; Reutter W; Fan H
    Glycobiology; 2011 Mar; 21(3):329-39. PubMed ID: 21045010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.
    Nadgir SM; Malviya M
    Neurochem Res; 2008 Nov; 33(11):2250-6. PubMed ID: 18437564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kinome wide screen identifies novel kinases involved in regulation of monoamine transporter function.
    Vuorenpää A; Ammendrup-Johnsen I; Jørgensen TN; Gether U
    Neurochem Int; 2016 Sep; 98():103-14. PubMed ID: 27020406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.
    Yasumoto S; Tamura K; Karasawa J; Hasegawa R; Ikeda K; Yamamoto T; Yamamoto H
    Neurosci Lett; 2009 May; 454(3):229-32. PubMed ID: 19429089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2.
    Finn JP; Edwards RH
    J Biol Chem; 1997 Jun; 272(26):16301-7. PubMed ID: 9195934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic neurons inhibit striatal output through non-canonical release of GABA.
    Tritsch NX; Ding JB; Sabatini BL
    Nature; 2012 Oct; 490(7419):262-6. PubMed ID: 23034651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The family of Na+/Cl- neurotransmitter transporters.
    Nelson N
    J Neurochem; 1998 Nov; 71(5):1785-803. PubMed ID: 9798903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics.
    Abramyan AM; Slack RD; Meena S; Davis BA; Newman AH; Singh SK; Shi L
    Neuropharmacology; 2019 Dec; 161():107411. PubMed ID: 30391505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.